The Nomination Committee of Elekta has been appointed
The Nomination Committee of Elekta has now been appointed in accordance with the AGM resolutions and following consultation with the company's largest owners.
AP4 is represented by Per Colleen, Head of Equities.
The other members of the committee is:
- Laurent Leksell, Chairman of the Board of Elekta
- Åsa Nisell, Swedbank Robur Funds
- John Hernander, Nordea Investment Funds
- Mikael Wiberg, Alecta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachyterapy, as well as workflow enhancing software systems across the spectrum of cancer care. The company is listed on NASDAQ Stockholm.